Zevra Therapeutics Inc (ZVRA)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -23.492 | -63.179 | -142.587 | -131.651 | -117.517 | -87.266 | -33.439 | -31.994 |
Return on Equity (%) | 114.627 | 113.856 | 91.014 | 34.778 | 18.116 | -207.218 | -39.021 | -62.367 |
Return on Invested Capital (%) | -103.685 | -71.745 | -281.273 | -316.085 | -326.913 | 13.796 | -44.118 | -72.425 |
Operating Margin (%) | N/A | N/A | N/A | -140.431 | -42.926 | -28.429 | -401.549 | -162.223 |
Net Profit Margin (%) | N/A | N/A | N/A | -190.996 | -96.026 | -219.536 | -397.237 | -167.689 |
Book Value Per Share | -1.276 | -3.924 | -2.516 | -2.048 | -14.638 | 3.63 | 2.484 | -0.333 |
Earnings Per Share | -1.128 | -2.96 | -2.134 | -0.675 | -2.812 | -1.796 | -1.202 | -1.271 |
Cash Per Share | 1.144 | 0.742 | 0.696 | 0.088 | 0.929 | 3.208 | 1.895 | 1.188 |
Working Capital Per Share | 4.623 | 2.421 | 0.443 | 0.033 | 0.186 | 3.165 | 2.353 | 0.365 |
Operating Profit Per Share | N/A | N/A | N/A | 0.272 | 2.641 | 0.759 | 0.293 | 0.704 |
EBIT Per Share | -1.129 | -2.963 | -2.139 | -0.675 | -2.82 | -0.243 | -1.225 | -1.271 |
EBITDA Per Share | -1.129 | -2.963 | -2.139 | -0.675 | -2.82 | -0.243 | -1.225 | -1.271 |
Free Cash Flow Per Share | -1.096 | -2.971 | -2.146 | -0.682 | -2.865 | -1.801 | -1.227 | -1.291 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 14,65M | 14,66M | 26,46M | 36,35M | 4,54M | 35,01M | 34,54M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 34,54M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | -405.974 | N/A | N/A | N/A | -465.898 | N/A | N/A |
Net Profit Margin (%) | N/A | -408.718 | N/A | N/A | N/A | -485.314 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 455,83M |
Ratio cours/bénéfice | -9,84 |
Ratio prix/ventes | 16,5 |
Ratio prix/liquidités | 10,53 |
Ratio prix/valeur comptable | 7,33 |
Rendement de dividende | - |
Actions en circulation | 53,38M |
Volume moyen (1 semaine) | 480,51k |
Volume moyen (1 mois) | 456,17k |
Variation sur 52 semaines | 77,96% |
Plus haut sur 52 semaines | 9,76 |
Plus bas sur 52 semaines | 4,20 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales